Sarepta Therapeutics Analysts Slash Their Forecasts After Q1 Results

benzinga.com/25/05/45252858/sarepta-therapeutics-analysts-slash-their-forecasts-after-q1-results

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) posted a loss for the first quarter on Tuesday.
Sarepta Therapeutics reported quarterly losses of $3.42 per share, which missed the analyst consensus estimate of losses of 95 cents. Quarterly revenue came in at $744.86 million, which beat the…

This story appeared on benzinga.com, 2025-05-07 13:28:40.
The Entire Business World on a Single Page. Free to Use →